SCHEMBL5753137

SCHEMBL5753137

O=C(Cl)c1cccc2cc(Oc3ccncc3)ccc12.O=C(Nc1cccc(Cl)c1)c1cccc2cc(Oc3ccncc3)ccc12

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 17/20 0.76
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
FLT1 P17948 2/20 0.49
FLT4 P35916 2/20 0.49
AURKA O14965 1/20 0.49
LCK P06239 1/20 0.49
CSF1R P07333 1/20 0.49
MET P08581 1/20 0.49
BRAF P15056 1/20 0.49
FGFR2 P21802 1/20 0.49
TEK Q02763 1/20 0.49
AURKB Q96GD4 1/20 0.49
GRM5 P41594 1/20 0.49
RET P07949 1/20 0.48
PDGFRB P09619 1/20 0.48
KIT P10721 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2746030 0.96 KDR (0.82) KDRCYP3A4CYP2D6SMN1; SMN2FLT1
SCHEMBL4548982 0.86 KDR (1.00) KDRCYP3A4CYP2D6FLT1FLT4
SCHEMBL4548985 0.85 KDR (0.81) KDRCYP3A4CYP2D6FLT1RET
SCHEMBL2747174 0.85 KDR (0.65) KDRCYP3A4CYP2D6AURKALCK
SCHEMBL4548984 0.83 KDR (0.72) KDRCYP3A4CYP2D6FLT1FLT4
SCHEMBL4548785 0.83 KDR (0.84) KDRFLT1FLT4RETPDGFRB
SCHEMBL4548910 0.82 KDR (0.84) KDRFLT1FLT4AURKALCK
SCHEMBL4548903 0.82 KDR (0.68) KDRFLT1FLT4AURKALCK
SCHEMBL4548986 0.82 KDR (0.76) KDRCYP3A4CYP2D6FLT1FLT4
SCHEMBL2747739 0.82 KDR (0.84) KDRFLT1FLT4AURKALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713484-A2 COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-10-25 EP disclosed
WO-2005070891-A2 COMPOUNDS AND METHODS OF USE AMGEN INC (US) 2005-08-04 WO disclosed